Regional Myocardial Perfusion during Ischemia
To the Editor:
In a recent article Maseri et al.' report their data on regional myocardial perfusion and its response to atrial pacing in a selected group of patients with coronary artery disease. Their conclusions include two postulates worth closer scrutiny: 1) some patients have ischemic myocardial areas even at rest, and 2) during ischemia induced by right atrial pacing the myocardial perfusion drops in some areas below the level prevailing at rest.
Analysis of the initial '35Xe slopes did not disclose any systematic difference between normal and poststenotic areas. This finding is in accord with the experience of others.2 s The conclusion of ischemia at rest was based on the 558Xe residual activity at the time when 90% of the tracer was washed out. This activity was systematically greater in poststenotic areas than in normal areas, whereas the activities were similar 15 minutes after the injection. The authors conclude that the latter finding rules out the impact of fatty tissue. This may not be necessarily true since the last part of the decay, deviating from the initial monoexponential slope, may well be due to the amount of nonmuscular tissue in the respective segments. Another possibility is the lack of collaterals in these patients, a very strange clinical situation since almost all patients with 2 90% coronary obstructions exhibit collateral vessels.' If the collaterals were really absent it would explain the difference in the final levels of the tracer by not contributing to the washout. In any event, a somewhat higher residual '58Xe activity in the poststenotic segments does not justify the conclusion of ischemia at rest, since this functional state is not analogous to a reduced myocardial perfusion in any given area.
The postulate that during ischemia the poststenotic regional perfusion drops below the basal level is not convincingly supported by the fragmentary data of Maseri et al. They say, "Although there was an increase in flow calculated for the whole heart during angina, similar to that reported in the literature and that observed in the control group, a severe reduction of myocardial perfusion relative to control areas occurred in poststenotic areas." My interpretation of this statement (no exact flow data presented) is that the flow increased in poststenotic areas to a lesser degree than in the normal areas. This would be in accord with the data of others.5 6 But the authors conclude in the last chapter of their discussion that " during severe ischemia induced by raising myocardial demands above the potential supply, flow to the ischemic area may become dramatically impaired because of the addition of functional factors which in some areas of the myocardium reduce blood supply far below the resting level." This would indicate a vasoconstrictive component during pacing-induced ischemia effectively counteracting the potent ischemic vasodilatation, a possibility which I consider very remote, but of great pathophysiological interest. An explanation based on raising left ventricular end-diastolic pressure upon ischemia is insufficient since this variable would affect the entire left ventricular subendocardium. Since the postulates of Maseri et al. concern the whole "cold spot" imaging currently widely practiced, the presentation of the relevant flow data at rest and upon ischemia with appropriate statistical treatment would be imperative and superior to and more convincing than portraying one single patient in two separate figures (figs. I and 5).
M. H. FRICK

University Central Hospital
Helsinki, Finland References The author replies:
To the Editor: Dr. Frick questions our interpretation of the Xenon'88 data reported in Circulation. For the studies at rest he raises three points. 1) He suggests that the finding of a consistently greater residual activity at 90% Xenon washout in poststenotic areas with similar Xenon accumulation at 15 minutes may be related to " . . nonmuscular tissue in the respective segments . . . " rather than to the presence of localized areas of reduced perfusion. This hypothesis appears hardly tenable because the presence of tissue with high Xenon solubility should also affect the 15 minutes distribution of the indicator.
2) Then Dr. Frick proceeds to suggest that the reduced flow in poststenotic areas may be explained by the absence of collaterals. This hypothesis is conceivable, although the absence of large visible collaterals does not rule out the presence of several nonvisible collaterals.
3) He points out that the presence of a regional reduction of perfusion cannot be equated with ischemia in its strict metabolic meaning. We share his opinion because a reduced flow may be associated with reduced local metabolic demand.
For the studies during ischemia caused by pacing-induced tachycardia Dr. Frick questions our conclusion that " . . . during severe ischemia flow to the ischemic area may become dramatically impaired because of the addition of functional factors." We derived this conclusion from the findings of reduced poststenotic washout rates when pacing above the anginal threshold was started immediately after the injection of Xenon. The findings, illustrated in figure 9 of our article, do not seem "fragmentary," as suggested by Dr. Frick, since all five patients in whom ischemia appeared soon after the onset of pacing, behaved in the same way. By contrast, regional Xenon washout rates observed following Xenon injection during pacing-induced angina show only a lesser degree of increase in poststenotic than in normal areas rather than a reduction relative to control. The interpretation of this apparent paradox is to be found in a severe degree of inhomogeneity of perfusion in the myocardium included within the solid angle of poststenotic regions which results in very little deposition of indicator in the areas with very low flow relative to those with high flow. Model simulations indicate that following bolus injection, initial washout rates reflect adequately average flow when differences in perfusion range from 1 to about 0.20, but they are negligibly influenced by flow values that are of the order of 1/10 of those in well perfused areas. Such a degree of flow reduction can be detected in washout curves when ischemia ensues after these areas have been labeled by the indicator, as we have done. This degree of inhomogeneity is probably not related to transmural differences in flow, but rather to overlapping of opposite walls with very different flows.
As to the interpretation of this impairment of perfusion during ischemia, the increase of left ventricular end-diastolic pressure affects predominantly the segments which have a low poststenotic perfusion pressure rather than the entire left ventricle to the same extent as Dr. Frick assumes. However, since the impairment of perfusion is so severe, other factors, such as steal or transmural flow redistribution and in particular vasospasml-' may play a substantial role. Therefore we definitely agree that the possibility of a functional reduction of perfusion must be given careful consideration in the interpretation of "cold spot" imaging.
Finally we wish to stress once more that the presence of Xenon recirculation and fat diffusion hold-up and of areas of severe flow reduction, do not justify the calculation of flow from initial slopes.4-5 These are the reasons why we did not feel entitled to present" Keeping an Eye on Circulation To the Editor:
I would like to report a new syndrome: Circulation -Precipitated Accelerated Presbyopia. The clinical pattern is clear: Circulation avidly tucked under the arm, the individual retreats into his study, but finds difficulty in reading. After adjusting his light and seat, he finds that by holding the journal at arms length he can barely make out most of what is written in the text, although references are hopeless. Being astute, he wonders if early presbyopia has struck. This hypothesis is tested by seeing if the same difficulty exists with other journals. It does not, and he decides that his diagnosis is incorrect.
Six to 12 months later presbyopia is clearly present; he discovers that even the morning newspaper must be read with arms outstretched.
Thus, not only is Circulation providing us with important new information in the field of cardiovascular disease, but has the extra benefit of giving early warning that clinically important presbyopia is imminent. ventricular conduction via the accessory pathway by digitalis as the cause of ventricular fibrillation in patients with pre-excitation syndrome and atrial fibrillation. However, careful analysis of their data failed to substantiate the conclusion. As they have noted, both the shortest and the average R-R intervals during atrial fibrillation in patients with ventricular fibrillation (group 2) were significantly shorter than those without ventricular fibrillation (group 1). Mean ± SEM shortest R-R interval was, respectively, 188 ± 8 and 278 ± 15 msec in patients with and without ventricular fibrillation (P < 0.001). Mean ± SEM average R-R interval was, respectively, 274 ± 19 and 370 ± 22 msec in patients with and without ventricular fibrillation (P < 0.01). Digitalis, given intravenously or orally, had no significant effects on either the shortest or the average R-R intervals. Mean ± SEM shortest R-R interval was 254 ± 17 msec before and 274 ± 27 msec after intravenous digoxin (N = 13) (NS), and was 256 ± 22 before and 247 ± 25 msec after oral digoxin (N = 10) (NS). Mean ± SEM average R-R interval was 366 + 23 before and 409 ± 55 msec after intravenous digoxin (N = 13) (NS), and was 354 ± 37 before and 340 ± 41 msec after oral digoxin (N = 10) (NS). It should also be noted that in eight of the nine patients in group 2, ventricular fibrillation developed one to 14 hours (mean 5 ± 4 hours) after the onset of atrial fibrillation. Thus, rapid ventricular rate with progressive hemodynamic deterioration and enhanced sympathetic activity over a prolonged period of time could lead to ventricular fibrillation. It could also contribute to the slightly increased ventricular rate prior to ventricular fibrillation in some patients, including the two with enhanced A-V nodal conduction and Mahaim fibre. Since there was no comparable group of patients with rapid ventricular rate in whom digitalis was not administered, the role of digitalis in the initiation of ventricular fibrillation could not be ascertained. Nevertheless, digitalis could increase ventricular vulnerability and be a contributing factor in the occurrence of ventricular fibrillation. The authors reply: To the Editor: It is not clear from his letter what statistical method Dr. Wu used to analyze our data. The correct method of analysis in this situation would be the paired t-test. We had performed this latter analysis in our initial evaluation of our data. This type of analysis of course assumes a unimodal distribution and it is clear from the amount of deviation that considerable scatter is present. It was for this very reason that we stated clearly in our paper that no a priori prediction of the effect of digitalis could be made. The direction and magnitude of change observed depended on the individual patient and not the dose of digoxin nor the value of the shortest R-R interval. Thus, despite the fact that there was no overall mean change in the intervals recorded before or after digitalis in the total group, definite shortening of the cycle length of the most rapid ventricular response was noted in one-third of the patients.
We agree with Dr. Wu that progressive hemodynamic deterioration over a prolonged period of time could certainly contribute to susceptibility to ventricular fibrillation and in this situation, delay of appropriate therapeutic measures because of the administration of digoxin could have contributed to a false association between drug administration and the onset of ventricular fibrillation. However, details of the clinical history not included in our manuscript because of space limitation suggest that this was not the case in most instances. Patient DE had multiple episodes of tachycardia lasting more than 4 hours. However, ventricular fibrillation only occurred after he had been administered intravenous digoxin. Atrial fibrillation induced in the absence of medication did not result in ventricular fibrillation. Patient KH had several episodes of tachycardia prior to his digitalization. Subsequent to his oral digitalization, he suffered ventricular fibrillation with his first and only episode of tachycardia. Patient SH had multiple episodes of atrial fibrillation prior to digitalization which lasted 5 to 6 hours or longer at a time. None of these deteriorated into ventricular fibrillation. However, after three separate courses of oral digoxin, she suffered ventricular fibrillation on each occasion she experienced atrial fibrillation. Once digoxin was discontinued, no further episodes of ventricular fibrillation occurred. Patient JM had multiple episodes of atrial flutter with 1:1 A-V conduction at 300 per minute lasting up to several hours. Only after oral digitalization did she develop ventricular fibrillation within 1 hour of onset of atrial flutter. Patient RR had multiple episodes of tachycardia prior to digitalization. However, following institution of digoxin, her next episode of arrhythmia deteriorated in one hour into ventricular fibrillation. The other patients mentioned in our paper had ventricular fibrillation occurring more than 4 hours after the onset of their tachyarrhythmia.
Since the submission of this manuscript, we have identified two additional patients who developed ventricular fibrillation only after digitalization. Since the response of an individual patient to digoxin cannot be predicted a priori, and since the ventricular response to atrial fibrillation became more rapid in one third of our patients after administration of digoxin, we believe that digoxin should be avoided in patients with the WPW syndrome unless the ventricular response during atrial fibrillation has been observed. 
Exercise and VPCs
The following is in response to Dr. David S. Sheps article entitled, Decreased frequency of exercise-induced ventricular ectopic activity in the second of two consecutive treadmill tests.
We cannot agree with the author's statement that consecutive testing is a poor method for studying exertional arrhythmia using standardized maximal treadmill tests. In the first place, none of our repeat tests were done at 45 minutes; this is clearly insufficient time for recovery as noted by the authors. Our studies showed slightly longer second tests with slightly higher maximal oxygen consumption (Ann Intern Med 80: 711, 1974). Recovery rate may be affected by fitness, a factor not considered by the authors.
Another factor which may influence the arrhythmia prevalence is selection of subjects. Many of our subjects were tested several times and showed frequent reproducible ventricular arrhythmia. Currently, we have in press a double-blind study which shows reproducibility as high as r = .99 for arrhythmia frequency.
There is some week to week variation but this can be partially adjusted for by considering % reduction with two consecutive tests. However, qualification of success with 100% supression would resolve many uncontrolled variables when testing an antiarrhythmic drug.
We agree that physiological variables should be reproduced insofar as possible since pressure-rate product is indirectly related to myocardial work. This is clearly altered with many of the antiarrhythmic drugs and may be the mechanism by which they are effective.
Psychological stress remains an uncontrolled variable related to arrhythmia which is only partially resolved with maximum testing in that variability of maximum values is significantly less than those at rest or submaximal exercise.
It is surprising that the study which shows an r correlation of .92 for frequency of arrhythmia and no significant change in severity of arrhythmia is probably the best correlation for reproducibility published for ambulatory patients. An optimistic view would be more realistic, r2 = .85 with .15 to be explained.
G. GEY, M.D. The Boeing Company R. A. BRUCE, M.D.
University of Washington Seattle, Washington
The authors reply: To the Editor:
We agree with Dr. Gey that one of the factors which may influence arrhythmia prevalence is selection of subjects. We stated clearly in the Materials and Methods section of our manuscript that the patients selected for our study were previously identified as having frequent ventricular premature beats (>10 VPCs) during or after maximal treadmill exercise. Thus, our patients represented a select group in which arrhythmias were previously shown to be reproducible on two separate tests done on separate days. Therefore, our results cannot be explained by nonreproducibility of exercise-induced VPCs.
Careful study of figure 1, which shows the relationship between the number of VPCs on Test I and Test 2, demonstrates that there is a good correlation (r = .92) between these two values. However, there is always a lower number of VPCs during the second test.
The study by Dr. Gey which he refers to employed a protocol similar to ours except for a rest period of one hour between tests, as compared to 45 minutes in our study. Reference to their table 1 reveals that resting heart rate is significantly higher (87 vs 73) and systolic blood pressure lower (118 vs 129) when Test II is compared to Test I. Systolic pressure is also lower at peak exercise in Test II vs Test I. Therefore, effects attributed to procainamide might just as well have been caused by the influence of a prior treadmill test. We must, therefore, reiterate our conclusions that this particular protocol cannot be used for the purpose of evaluating antiarrhythmic efficacy. DAVID that repeated, noninvasive evaluation of patients with mitral valve prolapse is of great practical importance. We agree with this and would like to point out the value of indirect (esophageal) left atrial pulse (ESO). The ESO is a noninvasive mechanogram which translates the variations of volume, and thus pressure, of the left atrium. The morphologic parallelism between the ESO and the direct left atrial pressure has been proven in both normal and pathologic conditions.`' The morphology of the normal ESO is similar to that of the jugulogram, showing positive "a", "c" and "v" waves, and negative "x" and "y" descents. In mitral insufficiency, the "x" descent becomes less evident, relative to the increase in amplitude and duration of the "v" wave. Isometric exercise (handgrip) and methoxamine infusion, which increase the degree of ventriculoatrial regurgitation, aggravate the signs of mitral insufficiency; amyl nitrite inhalation diminishes the degree of ventriculo-atrial regurgitation.3 In mitral stenosis the descending part of the "v" wave is slowed and/or suddenly changes in direction in coincidence with the opening snap.
We have used the ESO in all our cases of mitral valve prolapse and found the following characteristic alterations of the tracings: a sudden change in slope after the "'x" point in coincidence with systolic click is always present; when there is a systolic murmur, the "'v" wave may be abnormally tall or substituted by a late systolic plateau beginning immediately after the click and continuing after the second heart sound.4 These alterations of the "v" wave are expressions of mitral valve regurgitation and are specific and sensitive enough to be both quantitative and qualitative.
We would like to emphasize that the ESO is the only noninvasive method which furnishes direct evidence of regurgitation associated with mitral valve prolapse.
